You are using an outdated browser. Please upgrade your browser to improve your experience.


Ligand Summary
Ligand Structure
Rendered image for the query structure
Copanlisib is an inhibitor of phosphatidylinositol-3-kinase (PI3K) with inhibitory activity predominantly against PI3K-alpha and PI3K-delta isoforms expressed in malignant B cells. Copanlisib has been shown to induce tumor cell death by apoptosis and inhibition of proliferation of primary malignant B cell lines. Copanlisib inhibits several key cell-signaling pathways, including B-cell receptor (BCR) signaling, CXCR12 mediated chemotaxis of malignant B cells, and NFkB signaling in lymphoma cell lines.
Synonyms & Links
DrugCentral: 5256
LyCHI:  H3234GC54PVS

Target Activities